• SENSEX 76,024.51
    -1,390.41 (--1.80%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • Vodafone Idea
    8.57 19.15(%)
  • Hind.Aeronautics
    4,492.80 5,675.00(%)
  • HBL Engineering
    532.15 738.65(%)
  • Reliance Industr
    1,250.00 1,156.00(%)
  • HDFC Bank
    1,765.00 1,430.15(%)
  • Galaxy Surfact.
    2,096.20 3,366.30(%)
  • Adani Green
    916.95 758.00(%)
  • ICICI Bank
    1,315.00 1,048.35(%)
  • Zomato Ltd
    205.00 304.50(%)
  • Larsen & Toubro
    3,430.60 3,141.30(%)
  • Infosys
    1,518.00 1,359.10(%)
  • Bajaj Finance
    8,672.00 6,376.55(%)
  • Dixon Technolog.
    12,880.05 7,100.05(%)
  • IndusInd Bank
    689.85 1,576.00(%)
  • ITC
    405.50 381.24(%)
  • Nip. India Gold
    77.05 77.05(%)
  • St Bk of India
    763.05 679.65(%)
  • M & M
    2,625.00 1,891.30(%)
  • Trent
    5,619.85 8,345.85(%)
  • PB Fintech.
    1,505.90 1,110.25(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Jubilant Pharmova Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Jubilant Bhartia
  • BSE Code : 592.0
  • ISIN : INE700A01033
917.00 21 (2.36%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    880.80

  • Today’s High

    928.70

  • Open

    885.00

  • Perv Close

    895.90

  • 52W Low

    566.60

  • 52W High

    1,309.90

Key Indicators

  • P/E(TTM)

    295.92

  • Mar.Cap (₹Cr.)

    14,607.81

  • Div & Yield %

    0.55

  • Book Value(₹)

    144.30

  • Debt-Equity Ratio

    2.36

  • AGM Date

    01-Apr-2025

  • EPS

    3.09

  • P/E Ratio

    295.92

Financials Ratios

  • Debt-Equity Ratio

    0.68

  • Mar.Cap (₹Cr.)

    14,607.81

  • RONW (%)

    0.76

  • ROCE (%)

    6.37

Score Board

  • Equity (₹ in Cr.)

    15.93

  • BV (₹)

    144.30

  • Sales( ₹ in Cr.)

    784.70

  • NP (in Cr.)

    32.36

  • NP Var(%)

    -35.0

  • Div%

    500.0

  • CPS (₹)

    5.10

  • EPS (₹)

    2.00

  • Traded Value (₹ in Lakhs)

    14,566.39

  • 52 Week High

    1,309.90

  • 52 Week Low

    566.60

  • Price BSE

    914.0

  • Price NSE

    917.00

  • Market Capital( in Cr.)

    14,566.39

  • P/C Ratio

    180.50

  • P/E Ratio

    450.00

  • Price Vs.BV

    2.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 784.70 810.10 87.75 2,709.50 3,139.90 3,438.61
Excise Duty 638.40 685.60 0.00 2,687.45 3,094.26 3,391.46
Net Sales 784.70 810.10 87.75 2,709.50 3,139.90 3,438.61
Other Income 103.40 137.90 125.87 47.88 173.23 78.00
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 888.10 948.00 213.62 2,757.38 3,313.13 3,516.61
EXPENDITURE :
Raw Materials 638.40 685.60 0.00 2,687.45 3,094.26 3,391.46
Power & Fuel Cost 638.40 685.60 0.00 2,687.45 3,094.26 3,391.46
Employee Cost 190.00 167.30 49.21 220.67 264.90 265.71
Other Manufacturing Expenses 6.10 7.70 8.29 14.07 38.26 46.87
Selling & Administrative Expenses 88.60 93.00 26.84 100.02 143.14 138.82
Miscellaneous Expenses 6.10 7.70 8.29 14.07 38.26 46.87
Less : Pre-operative Expenses Capitalised :
Total Expenditure 846.40 868.70 131.37 2,484.21 3,012.59 3,333.18
Operating Profit 128.00 124.40 10.18 497.32 638.26 613.52
Interest 29.90 18.50 30.59 101.80 136.20 128.96
Gross Profit 41.70 79.30 82.25 273.17 298.84 183.43
Depreciation 48.30 43.20 6.25 99.97 107.40 86.48
Profit Before Tax 41.70 79.30 82.25 273.17 298.84 183.43
Tax 6.80 13.80 13.66 45.44 26.13 31.08
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.30 15.60 -9.91 13.25 -48.43 4.72
Reported Net Profit 31.60 49.90 78.50 214.48 321.14 147.63
Extraordinary Items 41.70 79.30 82.25 273.17 298.84 183.43
Adjusted Net Profit 31.60 49.90 78.50 214.48 321.14 147.63
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 79.60 79.64 79.64 79.64 79.64 71.68
P & L Balance carried down 31.60 49.90 78.50 214.48 321.14 147.63
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 500.00 500.00 500.00 500.00 500.00 450.00
Dividend Per Share(Rs) 5.00 5.00 5.00 5.00 5.00 4.50
Earnings Per Share-Unit Curr 1.99 3.13 4.93 13.47 20.16 9.27
Book Value 79.60 79.64 79.64 79.64 79.64 71.68
Book Value(Adj)-Unit Curr 79.60 79.64 79.64 79.64 79.64 71.68

Shareholding Pattern

  • Promoter Group

    50.68%

  • Public Share Holding

    48.77%

  • Custodian

    0.56%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 5,230,455 3.28 5,230,455 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 5,000 5,000.00 5,000 5,000
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 5,235,455 3.29 5,235,455 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 73,583,176 46.20 73,583,176 6
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,898,425 1.19 1,898,425 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 75,481,601 47.39 75,481,601 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,645 0.00 2,045 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 27,015,311 16.96 27,015,311 149
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,238,102 1.41 2,238,102 3
Mutual Funds / UTI 5,791,314 3.64 5,791,314 17
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,080,515 1.93 3,080,515 14
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 38,127,887 23.94 38,127,287 185
2] Non Institution
Bodies Corporate 5,035,059 3.16 5,034,809 760
Clearing Members 450,785 0.28 450,785 29
Directors of their Relatives 2,794 0.00 2,794 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,834,161 1.15 1,812,721 2,723
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 826,729 0.52 826,729 1,702
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,472,000 6.57 10,472,000 3
Individuals holding nominal share capital up to Rs. 1 lakh 18,343,446 11.52 17,959,581 96,918
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 13,746 0.01 13,746 6
Others 1,994,498 1.25 1,994,498 1
Sub Total 39,551,786 24.83 39,146,231 102,244
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 884,410 0.56 884,410 1
Total Shares held by Custodians and against which Depository Receipts have been issued 884,410 0.56 884,410 1
Grand Total ( A + B + C ) 159,281,139 100.00 158,874,984 102,442

Company Background

Jubilant Pharmova LtdPharmaceuticals - Indian - Bulk Drugs

  • Jubilant Pharmova Ltd
  • BSE Code : 592.0
  • ISIN : INE700A01033

  • Incorporation Year

    1978

  • Registered Office

    Bhartiagram Gajraula
    , Amroha,
    Uttar Pradesh-244223

  • Telephone

    91-5924-267200

  • FAX

    91-5924-4264895/96

  • Chairman

    Shyam S Bhartia

  • Managing Director

    Priyavrat Bhartia

  • Company Secretary

    Naresh Kapoor

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Alankit Assignments Ltd
    Alankit Heights ,
    1E/13 Jhandewalan Ex,
    Mumbai - New Delhi-110055

Jubilant Pharmova Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Jubilant Pharmo 914.40 888.10 784.70 382.59 2.57
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92